Mandate

Vinge has advised Sileon in connection with its rights issue

October 23, 2023 M&A

Vinge has advised Sileon AB (publ) in connection with its rights issue, which provides the company with proceeds of approximately SEK 33.8 million before deduction of transaction costs.

The rights issue is primarily intended to finance ongoing commercialization activities, product development, and general working capital. Sileon is a global fintech company that offers an innovative card-based Buy Now Pay Later (BNPL) SaaS functionality to banks, card issuers and fintechs. Sileon is listed on Nasdaq First North Growth Market.

Vinge’s team consisted of Anders Strid, Edin Agic och Adrian Filipovic.

  

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026